Published in TB and Outbreaks Week, May 11th, 1998
The simple and inexpensive test could one day extend multidrug-resistance testing to areas which currently have little access to existing lab-intensive tests, researchers say.
"The MTT assay could, in combination with a test to detect resistance to isoniazid, be a cheap and rapid screening method for multidrug-resistant Mycobacterium tuberculosis that is affordable even by low-income countries where tuberculosis is a major public health problem," Robert N. Mshana and colleagues from Ethiopia's Armauer Hansen Research...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.